{"took":5,"total":348908,"max_score":0.0,"hits":[{"_id":"DOID:0050537","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:83","DOID:110","DOID:5614","DOID:0050177","DOID:630","DOID:0050155","DOID:863","DOID:7","DOID:4"],"children":[],"def":"\"A cataract that is characterized by a distinctive discoid lens opacity situated posteriorly and adjacent to the posterior capsule.\" [url:https\\://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729648/]","descendants":[],"doid":"DOID:0050537","name":"posterior polar cataract","parents":["DOID:83"],"synonyms":{"exact":["CATARACT, POSTERIOR POLAR"]},"xrefs":{}}},{"_id":"DOID:0051078","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:557","DOID:0080205","DOID:18","DOID:7","DOID:4"],"children":[],"def":"\"A congenital anomalies of the kidney and urinary tract that has_material_basis_in heterozygous mutation in the NRIP1 gene on chromosome 21q11-q21.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/28381549/]","descendants":[],"doid":"DOID:0051078","name":"congenital anomalies of the kidney and urinary tract 3","parents":["DOID:0080205"],"synonyms":{"exact":["congenital anomalies of kidney and urinary tract 3"]},"xrefs":{"mim":"618270"}}},{"_id":"DOID:0051080","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:0050739","DOID:10983","DOID:0050177","DOID:630","DOID:225","DOID:0050737","DOID:4"],"children":[],"def":"\"An Alport syndrome that is characterized by glomerular basement membrane abnormalities and that has_material_basis_in homozygous or compound heterozygous mutation in the COL4A3 gene on chromosome 2q36. Sensorineural hearing loss and ocular manifestations may be present.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/9792860/]","descendants":[],"doid":"DOID:0051080","name":"Alport syndrome 3B","parents":["DOID:0050737","DOID:10983"],"synonyms":{},"xrefs":{"gard":"625","mim":"620536","ordo":"88919"}}},{"_id":"DOID:0051081","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:0050736","DOID:2975","DOID:0050739","DOID:557","DOID:0050177","DOID:898","DOID:630","DOID:0080322","DOID:18","DOID:7","DOID:4"],"children":[],"def":"\"An autosomal dominant polycystic kidney disease that is characterized by enlarged kidneys, arterial hypertension, and kidney failure and that has_material_basis_in heterozygous mutation in the NEK8 gene on chromosome 17q11.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/37598857/]","descendants":[],"doid":"DOID:0051081","name":"polycystic kidney disease 8","parents":["DOID:898"],"synonyms":{},"xrefs":{"mim":"620903"}}},{"_id":"DOID:0051082","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:331","DOID:1289","DOID:4","DOID:14330","DOID:0050890","DOID:7","DOID:863"],"children":[],"def":"\"A Parkinson's disease that has_material_basis_in mutation in the GBA1 gene on chromosome 1q22.\" [url:https\\://pmc.ncbi.nlm.nih.gov/articles/PMC11241486/]","descendants":[],"doid":"DOID:0051082","name":"Parkinson's disease 27","parents":["DOID:14330"],"synonyms":{},"xrefs":{}}},{"_id":"DOID:0051083","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:331","DOID:0050739","DOID:0050177","DOID:630","DOID:863","DOID:0050701","DOID:0050737","DOID:936","DOID:7","DOID:4","DOID:1826","DOID:0112202"],"children":[],"def":"\"A developmental and epileptic encephalopathy that is characterized by early-onset refractory seizures, global developmental delay, hypotonia, impaired gross motor development, impaired intellectual development, and absent speech and that has_material_basis_in homozygous mutation in the DEPDC5 gene on chromosome 22q12.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/36067010/]","descendants":[],"doid":"DOID:0051083","name":"developmental and epileptic encephalopathy 111","parents":["DOID:0050737","DOID:0112202"],"synonyms":{},"xrefs":{"mim":"620504"}}},{"_id":"DOID:0051084","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:0050736","DOID:331","DOID:0050739","DOID:0050177","DOID:630","DOID:863","DOID:0050701","DOID:936","DOID:7","DOID:4","DOID:1826","DOID:0112202"],"children":[],"def":"\"A developmental and epileptic encephalopathy that is characterized by a wide range of seizure types, including focal and generalized seizures and that has_material_basis_in heterozygous mutation in the KCNH5 gene on chromosome 14q23.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/36307226/]","descendants":[],"doid":"DOID:0051084","name":"developmental and epileptic encephalopathy 112","parents":["DOID:0050736","DOID:0112202"],"synonyms":{},"xrefs":{"mim":"620537"}}},{"_id":"DOID:0051085","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:331","DOID:0050739","DOID:0050177","DOID:630","DOID:863","DOID:0050701","DOID:0050737","DOID:936","DOID:7","DOID:4","DOID:1826","DOID:0112202"],"children":[],"def":"\"A developmental and epileptic encephalopathy that is characterized by severe early-onset recurrent epilepsy, which is worsened by treatment with levetiracetam and that has_material_basis_in homozygous mutation in the SV2A gene on chromosome 1q21.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/37985816/]","descendants":[],"doid":"DOID:0051085","name":"developmental and epileptic encephalopathy 113","parents":["DOID:0050737","DOID:0112202"],"synonyms":{},"xrefs":{"mim":"620772"}}},{"_id":"DOID:0051086","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:0050736","DOID:331","DOID:0050739","DOID:0050177","DOID:630","DOID:863","DOID:0050701","DOID:936","DOID:7","DOID:4","DOID:1826","DOID:0112202"],"children":[],"def":"\"A developmental and epileptic encephalopathy that is characterized by moderately to severely impaired intellectual development, onset of epilepsy within the first 18 months of life, and a choreiform, dystonic, or dyskinetic movement disorder and that has_material_basis_in heterozygous mutation in the SLC32A1 gene on chromosome 20q11.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/36073542/]","descendants":[],"doid":"DOID:0051086","name":"developmental and epileptic encephalopathy 114","parents":["DOID:0050736","DOID:0112202"],"synonyms":{},"xrefs":{"mim":"620774"}}},{"_id":"DOID:0051087","_score":0.0,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:331","DOID:0050739","DOID:0050177","DOID:630","DOID:863","DOID:0050701","DOID:0050737","DOID:936","DOID:7","DOID:4","DOID:1826","DOID:0112202"],"children":[],"def":"\"A developmental and epileptic encephalopathy that is characterized by severe developmental delay and epileptic encephalopathy, massive reduction of white matter, hypo-/aplasia of the corpus callosum, neurodevelopmental arrest, and early death and that has_material_basis_in homozygous or compound heterozygous mutation in the SNF8 gene on chromosome 17q21.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/38423010/]","descendants":[],"doid":"DOID:0051087","name":"developmental and epileptic encephalopathy 115","parents":["DOID:0050737","DOID:0112202"],"synonyms":{},"xrefs":{"mim":"620783"}}}]}